Literature DB >> 9203659

Epitope repertoire of human CD4+ T cells on tetanus toxin: identification of immunodominant sequence segments.

B M Diethelm-Okita1, R Raju, D K Okita, B M Conti-Fine.   

Abstract

Sequence regions of tetanus toxin-forming CD4+ cell epitopes in 8 HLA-disparate subjects were identified. Overlapping synthetic peptides corresponding to the complete tetanus toxin sequence were used to test, in a proliferation assay, unselected blood CD4+ cells or CD4+ cell lines propagated by stimulation with tetanus toxoid. The CD4+ cell lines recognized most peptides recognized by the blood CD4+ cells and they recognized additional peptides. Their responses were stronger than those of unselected blood CD4+ cells. Two peptides were recognized by all subjects: one largely overlapped a tetanus toxin sequence region previously identified as a "universal" T cell epitope. Thirteen other peptides elicited a CD4+ cell response in 6 or 7 of the 8 subjects, and another 10 elicited responses in 5 subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203659     DOI: 10.1093/infdis/175.2.382

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Isolation and characterization of new human carrier peptides from two important vaccine immunogens.

Authors:  Paeton L Wantuch; Lina Sun; Rachel K LoPilato; Jarrod J Mousa; Robert S Haltiwanger; Fikri Y Avci
Journal:  Vaccine       Date:  2020-01-28       Impact factor: 3.641

2.  Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences.

Authors:  P I Karachunski; N S Ostlie; D K Okita; B M Conti-Fine
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

3.  Reduction of human anti-tetanus toxoid antibody in hu-PBL-SCID mice by immunodominant peptides of tetanus toxoid.

Authors:  D J Jackson; C J Elson; B M Kumpel
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

4.  Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+IFNγ- Thpp cells.

Authors:  Nan Deng; Jason M Weaver; Tim R Mosmann
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

5.  Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses.

Authors:  Ricardo da Silva Antunes; Sinu Paul; John Sidney; Daniela Weiskopf; Jennifer M Dan; Elizabeth Phillips; Simon Mallal; Shane Crotty; Alessandro Sette; Cecilia S Lindestam Arlehamn
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

6.  Pain Management in a Model of Interstitial Cystitis/Bladder Pain Syndrome by a Vaccinal Strategy.

Authors:  Céline Augé; Lilian Basso; Catherine Blanpied; Nathalie Vergnolle; Xavier Gamé; Sophie Chabot; Philippe Lluel; Gilles Dietrich
Journal:  Front Pain Res (Lausanne)       Date:  2021-03-08

7.  Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults.

Authors:  Laura F Su; Brian A Kidd; Arnold Han; Jonathan J Kotzin; Mark M Davis
Journal:  Immunity       Date:  2013-02-07       Impact factor: 31.745

8.  Increase in IFNγ(-)IL-2(+) cells in recent human CD4 T cell responses to 2009 pandemic H1N1 influenza.

Authors:  Jason M Weaver; Hongmei Yang; David Roumanes; F Eun-Hyung Lee; Hulin Wu; John J Treanor; Tim R Mosmann
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

9.  Recognition of higher order patterns in proteins: immunologic kernels.

Authors:  Robert D Bremel; E Jane Homan
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  SWIFT-scalable clustering for automated identification of rare cell populations in large, high-dimensional flow cytometry datasets, part 2: biological evaluation.

Authors:  Tim R Mosmann; Iftekhar Naim; Jonathan Rebhahn; Suprakash Datta; James S Cavenaugh; Jason M Weaver; Gaurav Sharma
Journal:  Cytometry A       Date:  2014-02-14       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.